TPO and autoimmune thrombocytopenic purpura: In the further analysis of 3299 publications, the research on pathophysiology and treatment of ITP was identified as the research hotspot, such as TPO-RAs, T cell subsets, etc. In addition, COVID-2019, Syk, and MSCs were emerging hot issues.